Denmark vs Hungary: The number of people with susceptibility test result for rifampicin
Denmark
113
in 2021
Hungary
142
in 2021
Denmark rank
106th
Hungary rank
103rd
The number of people with susceptibility test result for rifampicin over time
- Denmark
- Hungary
How they compare
Hungary currently reports 142 against 113 in Denmark, a difference of 29.
That makes Hungary's figure about 1.3 times Denmark's.
Across all 5 years both countries report, Hungary has been ahead every year.
Denmark ranks 106th and Hungary ranks 103rd of 155 countries.
Hungary has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Denmark | Hungary | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 162 | 277.33 | 115.33 | Hungary |
| 2020s | 120.5 | 149 | 28.5 | Hungary |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Denmark or Hungary?
- Hungary, at 142 against 113 in Denmark as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Denmark and Hungary?
- 29, with Hungary ahead.
- How many years of comparable data are there for Denmark and Hungary?
- 5 years are reported by both, from 2017 to 2021.
- How do Denmark and Hungary rank globally for the number of people with susceptibility test result for rifampicin?
- Denmark ranks 106th and Hungary ranks 103rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.